Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rate. (2021)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/pst.2059
PubMed Identifier: 32790026
Publication URI: http://europepmc.org/abstract/MED/32790026
Type: Journal Article/Review
Volume: 20
Parent Publication: Pharmaceutical statistics
Issue: 1
ISSN: 1539-1604